Report: Market for Cannabis Infused Products to Grow from $29 Billion to $150 Billion by 2030

According to a new Cannabis Infused Products Market report, the market is currently valued at $29.68 billion and is expected to grow at an incredible rate to reach a value of $150.1 billion by 2030.

Data Bridge Market Research analyses that the cannabis infused products market which was USD 29.68 billion in 2022, would rocket up to USD 150.51 billion by 2030, and is expected to undergo a compound annual growth rate (CAGR) of 22.5% during the forecast period 2023 to 2030.

According to the report, the cannabis infused products market is expected to witness significant growth during the forecast period of 2023-2030. The increasing number of scientific trials of cannabis-infused medications for various therapeutic areas, particularly cannabidiol use, is driving market growth. Furthermore, the narrative among physicians about the benefits of cannabis-infused medicines, as well as supporting clinical evidence, is leading to an increase in patient prescriptions for cannabis-infused medicines.

Below are the drivers of this rapid growth:

  • Use in various disorders

Cannabis is increasingly recognized as an effective treatment for many conditions, including nausea and vomiting brought by chemotherapy, restlessness, muscle tightness, and chronic discomfort. The bulk of firms are moving forward quickly with their investigations into the therapeutic potential of hemp and cannabis.

  • Cannabinol and Tetrahydrocannabinol-modified edibles

CBD and THC-infused edibles are becoming increasingly popular in all legal states. Furthermore, customers and investors are becoming more interested in infused beverages. The complex administrative process for cannabis acceptance can stymie industry growth. The therapeutic properties of cannabis and the ongoing legalization of cannabis capsules will serve as opportunities for market expansion.

  • Increasing legalization of cannabis

The majority of cannabis users in American states and provinces that have legalized the drug are over 50. It is expected that this demographic will lead to a rise in cannabis demand in the nation due to a higher likelihood of chronic diseases. After the age of 50 and cannabis’ efficacy in treating these disorders, cannabis’s popularity and demand are expected to rise in the future, due to continuous research and product standardization for medicinal uses.

The Cannabis Infused Products Market is Dominated by Firms Such as

  • Joy Organics (U.S.)
  • CBD istillery (U.S.)
  • Gaia Botanicals (U.S.)
  • Harmony (U.S.)
  • Floyd’s of Leadville (U.S.)
  • Lazarus Naturals (U.S.)
  • cbdMD (U.S.)
  • Pure Hemp Botanicals (U.S.)
  • ENDOCA(Netherlands)
  • Green Roads (U.S.)
  • Tilray (U.S.)
  • Canopy Growth Corp. (Canada)
  • GW Pharmaceuticals PLC (U.K.)
  • Aurora Cannabis (Canada)
  • Aphria Inc. (Canada)
  • CV sciences Inc. (U.S.)

To Get Full PDF Research Report, Visit: https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-cannabis-infused-products-market